Skip to main content
Terug
Watch Compare

Trulieve Cannabis Corp.

Datakwaliteit: 100%
TCNNF
OTC Manufacturing Chemicals
€ 6,18
▲ € 0,16 (2,66%)
Marktkapitalisatie: 1,19 B
Prijs
€ 6,18
Marktkapitalisatie
1,19 B
Dagbereik
€ 6,10 — € 6,48
52-Weeksbereik
€ 3,25 — € 11,83
Volume
41.340
Openen € 6,10
50D / 200D Gem.
€ 6,50
4,94% below
50D / 200D Gem.
€ 6,72
8,04% below

Quick Summary

Belangrijkste Punten

Revenue grew 5,92% annually over 5 years — modest growth
Debt/Equity of 0,31 — conservative balance sheet
Generating 228,63 M in free cash flow
Revenue growth is decelerating — 1Y growth trails 5Y average by 6,37%
Capital efficient — spends only 3,74% of revenue on capex
ROIC of 2,56% — low return on invested capital

Groei

Revenue Growth (5Y)
5,92%
Onder sectorgemiddelde (9,35%)
Revenue (1Y)-0,45%
Earnings (1Y)N/A
FCF Growth (3Y)19,00%

Kwaliteit

Return on Equity
-10,21%
Boven sectorgemiddelde (-51,02%)
ROIC2,56%
Net Margin-10,35%
Op. Margin12,15%

Veiligheid

Debt / Equity
0,31
Onder sectorgemiddelde (0,33)
Current Ratio6,09
Interest Coverage2,26

Waardering

PE (TTM)
-9,73
Onder sectorgemiddelde (-1,98)
P/B Ratio1,00
EV/EBITDA4,24
Dividend YieldN/A

Koershistorie

Financiële Trends

Sectorvergelijking

vs Manufacturing sector mediaan (44 peers)
Metriek Aandeel Sector Mediaan
P/E -9,7 -2,0
P/B 1,0 5,1
ROE % -10,2 -51,0
Net Margin % -10,4 -150,2
Rev Growth 5Y % 5,9 9,3
D/E 0,3 0,3

All Fundamental Metrics
Growth
Revenue Growth (1Y) -0,45% Revenue Growth (3Y) 2,28%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) 5,92% Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 1,18 B Net Income (TTM) -122,25 M
ROE -10,21% ROA -4,17%
Gross Margin 60,21% Operating Margin 12,15%
Net Margin -10,35% Free Cash Flow (TTM) 228,63 M
ROIC 2,56% FCF Growth (3Y) 19,00%
Safety
Debt / Equity 0,31 Current Ratio 6,09
Interest Coverage 2,26 Asset Turnover 0,40
Working Capital 632,31 M Tangible Book Value -112,94 M
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -9,73 Forward P/E N/A
P/B Ratio 1,00 P/S Ratio 1,01
PEG Ratio N/A Forward PEG N/A
EV/EBITDA 4,24 Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield 19,22%
Market Cap 1,19 B Enterprise Value 1,11 B
Per Share
EPS (Diluted TTM) -0,58 Revenue / Share 6,14
FCF / Share 1,19 OCF / Share 1,42
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue 3,74% FCF Conversion -187,02%
SBC-Adj. FCF 206,67 M Growth Momentum -6,37

Income Statement

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Revenue 1,18 B 1,19 B 1,13 B 1,24 B 938,39 M
Net Income -122,25 M -160,58 M -533,14 M -252,73 M 17,45 M
EPS (Diluted) -0,58 -0,79 -2,28 -1,06 0,12
Gross Profit 711,17 M 715,75 M 588,63 M 681,99 M 566,13 M
Operating Income 143,50 M 97,78 M -221,61 M 32,41 M 196,95 M
EBITDA — — — — —
R&D Expenses — — — — —
SG&A Expenses 445,21 M — — — —
D&A 117,63 M 112,81 M 109,83 M 119,37 M 48,10 M
Interest Expense 63,45 M 62,19 M 81,57 M 79,77 M 34,79 M
Income Tax 208,11 M 197,59 M 151,36 M 161,82 M 146,06 M

Balance Sheet

Annual, most recent first
Metric FY2025 FY2024 FY2023 FY2022 FY2021
Total Assets 2,70 B 2,87 B 2,73 B 3,40 B 3,41 B
Total Liabilities 1,55 B 1,62 B 1,32 B 1,47 B 1,26 B
Shareholders' Equity 1,14 B 1,25 B 1,41 B 1,93 B 2,15 B
Total Debt 136,74 M 364,84 M 363,22 M 541,66 M 462,93 M
Cash & Equivalents 255,54 M 238,80 M 201,37 M 212,27 M 230,65 M
Current Assets 562,72 M 604,56 M 477,35 M 592,95 M 524,42 M
Current Liabilities 126,95 M 138,49 M 114,85 M 209,70 M 168,94 M